{
    "organizations": [],
    "uuid": "a46cf18c646f4511a56a98f54cdf335cfa5c4d2d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abbvie-canada-says-canadians-diagn/brief-abbvie-canada-says-canadians-diagnosed-with-advanced-parkinsons-disease-living-in-nova-scotia-now-have-public-access-to-duodopa-idUSFWN1QC0M7",
    "ord_in_thread": 0,
    "title": "BRIEF-Abbvie Canada Says ‍Canadians Diagnosed With Advanced Parkinson's Disease Living In Nova Scotia Now Have Public Access To Duodopa​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Regulatory News - Americas  31 PM / in 5 minutes BRIEF-Abbvie Canada Says ‍Canadians Diagnosed With Advanced Parkinson's Disease Living In Nova Scotia Now Have Public Access To Duodopa​ Reuters Staff 1 Min Read Feb 22 (Reuters) - Abbvie Inc: * ABBVIE CANADA - ‍CANADIANS DIAGNOSED WITH ADVANCED PARKINSON‘S DISEASE LIVING IN NOVA SCOTIA NOW HAVE PUBLIC ACCESS TO DUODOPA​ Source text for Eikon:  ",
    "published": "2018-02-22T14:31:00.000+02:00",
    "crawled": "2018-02-22T14:45:46.071+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "regulatory",
        "news",
        "america",
        "pm",
        "minute",
        "canada",
        "say",
        "diagnosed",
        "advanced",
        "parkinson",
        "disease",
        "living",
        "nova",
        "scotia",
        "public",
        "access",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "abbvie",
        "inc",
        "abbvie",
        "canada",
        "diagnosed",
        "advanced",
        "parkinson",
        "disease",
        "living",
        "nova",
        "scotia",
        "public",
        "access",
        "source",
        "text",
        "eikon"
    ]
}